Interlife Holdings Co (TSE:1418) Research & Development: 円0 Mil (TTM As of Feb. 2026)


TSE:1418 Interlife Holdings Co Ltd TSE:1418
70 GF Score
Price 円517.00
GF Value 円359.34
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Interlife Holdings Co Research & Development?

Interlife Holdings Co TSE:1418 +0.19% 70 Research & Development is 円0 Mil as of Feb. 2026. GuruFocus rates TSE:1418 with a GF Score™ of 70/100 and a GF Value™ of 円359.34 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Interlife Holdings Co's Research & Development for the six months ended in Feb. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 was 円0 Mil.

Interlife Holdings Co  (TSE:1418) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Interlife Holdings Co Research & Development Related Terms

Interlife Holdings Co Research & Development Historical Data

* Premium members only.

The historical data trend for Interlife Holdings Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Interlife Holdings Co Research & Development Chart

Interlife Holdings Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Interlife Holdings Co Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:1418
70GF Score
Interlife Holdings Co Ltd TSE:1418
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Interlife Holdings Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Interlife Holdings Co (TSE:1418) has a Research & Development of 円0 Mil as of Feb. 2026. Research and development expense is the total cost for research and development activities. View historical data on Interlife Holdings Co and its competitors.
Is Interlife Holdings Co's Research & Development too high?
Interlife Holdings Co's current Research & Development is 円0 Mil. Overall, Interlife Holdings Co has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Interlife Holdings Co's Research & Development compare to CTAS and CPRT?
Interlife Holdings Co's Research & Development of 円0 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Business Services company?
A good Research & Development depends on the Business Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Interlife Holdings Co and its competitors. Interlife Holdings Co's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Interlife Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Interlife Holdings Co (TSE:1418) is currently considered Significantly Overvalued. The stock's GF Value™ is 円359.34, compared to a current price of 円517.00 — trading 43.9% above its estimated fair value. The current Research & Development is 円0 Mil. Interlife Holdings Co's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Interlife Holdings Co (TSE:1418), the current Research & Development is 円0 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Interlife Holdings Co (TSE:1418) Overvalued in 2026?

Based on GuruFocus' analysis, Interlife Holdings Co stock appears to be overvalued. The current stock price of 円517.00 is trading 43.9% above its estimated GF Value™ of 円359.34. GuruFocus considers Interlife Holdings Co to be Significantly Overvalued.

Key valuation signals for TSE:1418:

  • Research & Development: 円0 Mil
  • GF Value™: 円359.34 vs. price of 円517.00 (43.9% above fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the TSE:1418 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Interlife Holdings Co Business Description

Address 13-16, Ginza 6-chome, 11th Floor, Ginza Wall Building, Chuo-ku, Tokyo, JPN, 104-0061
Interlife Holdings Co Ltd through its subsidiaries, is engaged in operating multiple businesses in Japan. Its core business segments include interior construction, audio and lighting equipment, and facilities and maintenance. The interior construction segment handles the design and planning of offices and amusement facilities. The audio and lighting equipment segment focuses on the planning, design, installation, and maintenance of audiovisual and lighting systems for various facilities. The facilities and maintenance segment provides services such as building cleaning, management, repair work, and air-conditioning maintenance. It generates the majority of its revenue from the interior construction segment.
70GF Score

Get the complete analysis for TSE:1418

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円517.00
Price
円359.34
GF Value